“Nanoparticle Formulation of a Poorly Soluble Kinase Inhibitor: A Technical Note on Scale-Up” (2022) Translational Medicine & Therapeutics Journal, 1(2), pp. 92–100. doi:10.5281/zenodo.22648994.